Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C18H32O2 |
| Molecular Weight | 280.4455 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 2 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCC\C=C/C\C=C/CCCCCCCC(O)=O
InChI
InChIKey=OYHQOLUKZRVURQ-HZJYTTRNSA-N
InChI=1S/C18H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10H,2-5,8,11-17H2,1H3,(H,19,20)/b7-6-,10-9-
Linoleic acid is a naturally occurring omega-6 essential fatty acid, present in a variety of foods, including the oils. Linoleic acid is a precursor for arachidonic acid biosynthesis; on the first enzymatic step of the pathway involves delta-6-desaturase, which converts linoleic acid to gamma-lenolenic acid. Linoleic acid has beneficial effects on human skin and hair. Replacement of saturated fat with linoleic acid is advocated to improve serum lipoprotein profiles and reduce the risk of coronary artery disease. Linoleic acid was tested in clinical trilas as a possible remedy against multiple sclerosis.
CNS Activity
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: GO:0008283 Sources: https://www.ncbi.nlm.nih.gov/pubmed/23341188 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Curative | Intralipid Approved UseIntralipid® 10% is indicated as a source of calories and essential fatty acids for patients requiring parenteral nutrition for extended periods of time (usually for more than 5 days) and as a source of essential fatty acids for prevention of EFAD. Launch Date1996 |
|||
| Primary | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Interaction of polyunsaturated fatty acids with animal cells and enveloped viruses. | 1980 Dec |
|
| Screening for new compounds with antiherpes activity. | 1984 Oct |
|
| Physiology and pathophysiology of organic acids in cerebrospinal fluid. | 1993 |
|
| Equilibrium constants for the binding of fatty acids with fatty acid-binding proteins from adipocyte, intestine, heart, and liver measured with the fluorescent probe ADIFAB. | 1994 Sep 30 |
|
| Fatty acids and fibrates are potent inducers of transcription of the phosphenolpyruvate carboxykinase gene in adipocytes. | 1995 Dec 1 |
|
| In Vivo Studies of the Biosynthesis of [alpha]-Eleostearic Acid in the Seed of Momordica charantia L. | 1997 Apr |
|
| Binding of prostaglandins to human PPARgamma: tool assessment and new natural ligands. | 2001 Apr 6 |
|
| Organotropic chemopreventive effects of n-3 unsaturated fatty acids in a rat multi-organ carcinogenesis model. | 2001 Nov |
|
| Arachidonic and linoleic acid metabolism in mouse intestinal tissue: evidence for novel lipoxygenase activity. | 2002 Feb 1 |
|
| Topical peroxisome proliferator activated receptor-alpha activators reduce inflammation in irritant and allergic contact dermatitis models. | 2002 Jan |
|
| Divergent effects of selective peroxisome proliferator-activated receptor-gamma 2 ligands on adipocyte versus osteoblast differentiation. | 2002 Jun |
|
| A human cell surface receptor activated by free fatty acids and thiazolidinedione drugs. | 2003 Feb 7 |
|
| High-fat feeding reduces endothelium-dependent vasodilation in rats: differential mechanisms for saturated and unsaturated fatty acids? | 2006 Aug |
|
| Differential activation of nuclear receptors by perfluorinated fatty acid analogs and natural fatty acids: a comparison of human, mouse, and rat peroxisome proliferator-activated receptor-alpha, -beta, and -gamma, liver X receptor-beta, and retinoid X receptor-alpha. | 2006 Aug |
|
| Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small molecules. | 2006 Jul |
|
| Comprehensive analysis of the effects of ordinary nutrients on hepatitis C virus RNA replication in cell culture. | 2007 Jun |
|
| Unsaturated fatty acids suppress the expression of the ATP-binding cassette transporter G1 (ABCG1) and ABCA1 genes via an LXR/RXR responsive element. | 2007 Mar |
|
| Characterization of Madin-Darby bovine kidney cell line for peroxisome proliferator-activated receptors: temporal response and sensitivity to fatty acids. | 2008 Jul |
|
| Comparison of hypolipidemic activity of synthetic gallic acid-linoleic acid ester with mixture of gallic acid and linoleic acid, gallic acid, and linoleic acid on high-fat diet induced obesity in C57BL/6 Cr Slc mice. | 2008 Jul 30 |
|
| Changing ratios of omega-6 to omega-3 fatty acids can differentially modulate polychlorinated biphenyl toxicity in endothelial cells. | 2008 Mar 10 |
|
| Sex hormone influence on hepatitis in young male A/JCr mice infected with Helicobacter hepaticus. | 2008 Sep |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C68398
Created by
admin on Mon Mar 31 17:45:00 GMT 2025 , Edited by admin on Mon Mar 31 17:45:00 GMT 2025
|
||
|
LOINC |
35165-0
Created by
admin on Mon Mar 31 17:45:00 GMT 2025 , Edited by admin on Mon Mar 31 17:45:00 GMT 2025
|
||
|
LOINC |
2564-3
Created by
admin on Mon Mar 31 17:45:00 GMT 2025 , Edited by admin on Mon Mar 31 17:45:00 GMT 2025
|
||
|
LOINC |
90917-6
Created by
admin on Mon Mar 31 17:45:00 GMT 2025 , Edited by admin on Mon Mar 31 17:45:00 GMT 2025
|
||
|
LOINC |
75117-2
Created by
admin on Mon Mar 31 17:45:00 GMT 2025 , Edited by admin on Mon Mar 31 17:45:00 GMT 2025
|
||
|
NCI_THESAURUS |
C2563
Created by
admin on Mon Mar 31 17:45:00 GMT 2025 , Edited by admin on Mon Mar 31 17:45:00 GMT 2025
|
||
|
CFR |
21 CFR 357.210
Created by
admin on Mon Mar 31 17:45:00 GMT 2025 , Edited by admin on Mon Mar 31 17:45:00 GMT 2025
|
||
|
CFR |
21 CFR 184.1065
Created by
admin on Mon Mar 31 17:45:00 GMT 2025 , Edited by admin on Mon Mar 31 17:45:00 GMT 2025
|
||
|
LOINC |
90915-0
Created by
admin on Mon Mar 31 17:45:00 GMT 2025 , Edited by admin on Mon Mar 31 17:45:00 GMT 2025
|
||
|
LOINC |
47686-1
Created by
admin on Mon Mar 31 17:45:00 GMT 2025 , Edited by admin on Mon Mar 31 17:45:00 GMT 2025
|
||
|
DSLD |
1537 (Number of products:578)
Created by
admin on Mon Mar 31 17:45:00 GMT 2025 , Edited by admin on Mon Mar 31 17:45:00 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
17351
Created by
admin on Mon Mar 31 17:45:00 GMT 2025 , Edited by admin on Mon Mar 31 17:45:00 GMT 2025
|
PRIMARY | |||
|
LINOLEIC ACID
Created by
admin on Mon Mar 31 17:45:00 GMT 2025 , Edited by admin on Mon Mar 31 17:45:00 GMT 2025
|
PRIMARY | |||
|
5200
Created by
admin on Mon Mar 31 17:45:00 GMT 2025 , Edited by admin on Mon Mar 31 17:45:00 GMT 2025
|
PRIMARY | |||
|
D019787
Created by
admin on Mon Mar 31 17:45:00 GMT 2025 , Edited by admin on Mon Mar 31 17:45:00 GMT 2025
|
PRIMARY | |||
|
9KJL21T0QJ
Created by
admin on Mon Mar 31 17:45:00 GMT 2025 , Edited by admin on Mon Mar 31 17:45:00 GMT 2025
|
PRIMARY | |||
|
60-33-3
Created by
admin on Mon Mar 31 17:45:00 GMT 2025 , Edited by admin on Mon Mar 31 17:45:00 GMT 2025
|
PRIMARY | |||
|
100000077113
Created by
admin on Mon Mar 31 17:45:00 GMT 2025 , Edited by admin on Mon Mar 31 17:45:00 GMT 2025
|
PRIMARY | |||
|
3323
Created by
admin on Mon Mar 31 17:45:00 GMT 2025 , Edited by admin on Mon Mar 31 17:45:00 GMT 2025
|
PRIMARY | |||
|
DB14104
Created by
admin on Mon Mar 31 17:45:00 GMT 2025 , Edited by admin on Mon Mar 31 17:45:00 GMT 2025
|
PRIMARY | |||
|
m6830
Created by
admin on Mon Mar 31 17:45:00 GMT 2025 , Edited by admin on Mon Mar 31 17:45:00 GMT 2025
|
PRIMARY | Merck Index | ||
|
C615
Created by
admin on Mon Mar 31 17:45:00 GMT 2025 , Edited by admin on Mon Mar 31 17:45:00 GMT 2025
|
PRIMARY | |||
|
281243
Created by
admin on Mon Mar 31 17:45:00 GMT 2025 , Edited by admin on Mon Mar 31 17:45:00 GMT 2025
|
PRIMARY | |||
|
5280450
Created by
admin on Mon Mar 31 17:45:00 GMT 2025 , Edited by admin on Mon Mar 31 17:45:00 GMT 2025
|
PRIMARY | |||
|
6400
Created by
admin on Mon Mar 31 17:45:00 GMT 2025 , Edited by admin on Mon Mar 31 17:45:00 GMT 2025
|
PRIMARY | |||
|
9KJL21T0QJ
Created by
admin on Mon Mar 31 17:45:00 GMT 2025 , Edited by admin on Mon Mar 31 17:45:00 GMT 2025
|
PRIMARY | |||
|
200-470-9
Created by
admin on Mon Mar 31 17:45:00 GMT 2025 , Edited by admin on Mon Mar 31 17:45:00 GMT 2025
|
PRIMARY | |||
|
70611
Created by
admin on Mon Mar 31 17:45:00 GMT 2025 , Edited by admin on Mon Mar 31 17:45:00 GMT 2025
|
ALTERNATIVE | |||
|
DTXSID2025505
Created by
admin on Mon Mar 31 17:45:00 GMT 2025 , Edited by admin on Mon Mar 31 17:45:00 GMT 2025
|
PRIMARY | |||
|
SUB14359MIG
Created by
admin on Mon Mar 31 17:45:00 GMT 2025 , Edited by admin on Mon Mar 31 17:45:00 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)